Findings From Severe Maternal Morbidity Surveillance and Review in Maryland.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 11 2022
Historique:
entrez: 29 11 2022
pubmed: 30 11 2022
medline: 2 12 2022
Statut: epublish

Résumé

In the US, more than 50 000 women experience severe maternal morbidity (SMM) each year, and the SMM rate more than doubled during the past 25 years. In response, professional organizations called for birthing facilities to routinely identify and review SMM events and identify prevention opportunities. To examine SMM levels, primary causes, and factors associated with the preventability of SMM using Maryland's SMM surveillance and review program. This cross-sectional study included pregnant and postpartum patients at 42 days or less after delivery who were hospitalized at 1 of 6 birthing hospitals in Maryland between August 1, 2020, and November 30, 2021. Hospital-based SMM surveillance was conducted through a detailed review of medical records. Hospitalization during pregnancy or within 42 days post partum. The main outcomes were admission to an intensive care unit, having at least 4 U of red blood cells transfused, and/or having COVID-19 infection requiring inpatient hospital care. A total of 192 SMM events were identified and reviewed. Patients with SMM had a mean [SD] age of 31 [6.49] years; 9 [4.7%] were Asian, 27 [14.1%] were Hispanic, 83 [43.2%] were non-Hispanic Black, and 68 [35.4%] were non-Hispanic White. Obstetric hemorrhage was the leading primary cause of SMM (83 [43.2%]), followed by COVID-19 infection (57 [29.7%]) and hypertensive disorders of pregnancy (17 [8.9%]). The SMM rate was highest among Hispanic patients (154.9 per 10 000 deliveries), primarily driven by COVID-19 infection. The rate of SMM among non-Hispanic Black patients was nearly 50% higher than for non-Hispanic White patients (119.9 vs 65.7 per 10 000 deliveries). The SMM outcome assessed could have been prevented in 61 events (31.8%). Clinician-level factors and interventions in the antepartum period were most frequently cited as potentially altering the SMM outcome. Practices that were performed well most often pertained to hospitals' readiness and adequate response to managing pregnancy complications. Recommendations for care improvement focused mainly on timely recognition and rapid response to such. The findings of this cross-sectional study, which used hospital-based SMM surveillance and review beyond the mere exploration of administrative data, offers opportunities for identifying valuable quality improvement strategies to reduce SMM. Immediate strategies to reduce SMM in Maryland should target its most common causes and address factors associated with preventability identified at individual hospitals.

Identifiants

pubmed: 36445707
pii: 2799025
doi: 10.1001/jamanetworkopen.2022.44077
pmc: PMC9709651
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2244077

Subventions

Organisme : NICHD NIH HHS
ID : P2C HD042854
Pays : United States

Références

J Clin Epidemiol. 2004 Jul;57(7):716-20
pubmed: 15358399
Obstet Gynecol. 2021 Jan 1;137(1):41-48
pubmed: 33278278
Obstet Gynecol. 2014 Aug;124(2 Pt 1):361-366
pubmed: 25004341
Obstet Gynecol. 2020 Apr;135(4):896-915
pubmed: 32168209
Obstet Gynecol. 2014 May;123(5):978-981
pubmed: 24785849
Anesth Analg. 2015 Jul;121(1):142-148
pubmed: 26091046
Am J Obstet Gynecol. 2016 Oct;215(4):509.e1-6
pubmed: 27210068
Am J Obstet Gynecol. 2014 May;210(5):435.e1-8
pubmed: 24295922
JAMA Netw Open. 2022 Jul 1;5(7):e2222966
pubmed: 35900764
Am J Perinatol. 2013 Jan;30(1):21-4
pubmed: 22814799
JAMA. 2022 Feb 22;327(8):748-759
pubmed: 35129581
BMJ Qual Saf. 2022 Sep;31(9):670-678
pubmed: 35428682
Am J Obstet Gynecol. 2016 May;214(5):643.e1-643.e10
pubmed: 26582168
J Perinatol. 2018 Aug;38(8):997-1008
pubmed: 29593355
Qual Health Res. 2005 Nov;15(9):1277-88
pubmed: 16204405
Am J Obstet Gynecol. 2014 Jun;210(6):557.e1-6
pubmed: 24508582
Obstet Gynecol. 2022 Feb 1;139(2):165-171
pubmed: 34991121
N Engl J Med. 2018 Nov 1;379(18):1689-1691
pubmed: 30380396
J Matern Fetal Neonatal Med. 2022 Jun;35(12):2234-2240
pubmed: 32594813
JAMA Netw Open. 2018 Nov 2;1(7):e184571
pubmed: 30646359
Am J Obstet Gynecol. 2016 Sep;215(3):B17-22
pubmed: 27560600
J Perinatol. 2006 Feb;26(2):79-84
pubmed: 16407964
Am J Obstet Gynecol. 2004 Sep;191(3):939-44
pubmed: 15467568

Auteurs

Carrie Wolfson (C)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Jiage Qian (J)

Department of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Pamela Chin (P)

Mercy Medical Center, Baltimore, Maryland.

Cathy Downey (C)

Howard County General Hospital, Columbia, Maryland.

Katie Jo Mattingly (KJ)

MedStar St Mary's Hospital, Leonardtown, Maryland.

Kimberly Jones-Beatty (K)

Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, Maryland.

Joanne Olaku (J)

Sinai Hospital of Baltimore, Baltimore, Maryland.

Sadaf Qureshi (S)

Luminis Health Anne Arundel Medical Center, Annapolis, Maryland.

Jane Rhule (J)

Independent researcher.

Danielle Silldorff (D)

Sinai Hospital of Baltimore, Baltimore, Maryland.

Robert Atlas (R)

Mercy Medical Center, Baltimore, Maryland.

Anne Banfield (A)

MedStar St Mary's Hospital, Leonardtown, Maryland.

Clark T Johnson (CT)

Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, Maryland.
Sinai Hospital of Baltimore, Baltimore, Maryland.
Department of Obstetrics and Gynecology, George Washington School of Medicine and Health Sciences, Washington, DC.

Donna Neale (D)

Howard County General Hospital, Columbia, Maryland.

Jeanne S Sheffield (JS)

Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, Maryland.

David Silverman (D)

Sinai Hospital of Baltimore, Baltimore, Maryland.

Kacie McLaughlin (K)

Maternal and Child Health Bureau, Health Resources and Services Administration, Rockville, Maryland.

Günes Koru (G)

Department of Health Policy and Management, University of Arkansas for Medical Sciences, Fayetteville.

Andreea A Creanga (AA)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Department of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH